Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MELPHALAN\MELPHALAN Cause Product use in unapproved indication? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product use in unapproved indication have been filed in association with MELPHALAN\MELPHALAN. This represents 23.1% of all adverse event reports for MELPHALAN\MELPHALAN.

6
Reports of Product use in unapproved indication with MELPHALAN\MELPHALAN
23.1%
of all MELPHALAN\MELPHALAN reports
0
Deaths
2
Hospitalizations

How Dangerous Is Product use in unapproved indication From MELPHALAN\MELPHALAN?

Of the 6 reports, 2 (33.3%) required hospitalization.

Is Product use in unapproved indication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MELPHALAN\MELPHALAN. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does MELPHALAN\MELPHALAN Cause?

Acute kidney injury (9) Chronic kidney disease (9) Drug ineffective (9) Thrombotic microangiopathy (9) Chronic graft versus host disease (7) Off label use (5)

What Other Drugs Cause Product use in unapproved indication?

DUPILUMAB (33,452) DICLOFENAC (12,197) METHOTREXATE (8,930) PREDNISONE (7,625) RITUXIMAB (7,519) MYCOPHENOLATE MOFETIL (5,910) ACETAMINOPHEN (5,819) CYCLOPHOSPHAMIDE (5,750) RISPERIDONE (5,551) TACROLIMUS (5,057)

Related Pages

MELPHALAN\MELPHALAN Full Profile All Product use in unapproved indication Reports All Drugs Causing Product use in unapproved indication MELPHALAN\MELPHALAN Demographics